phase i study of cd22-targeted car-t therapy in patients with cd19-negative b-all
Published 1 year ago • 275 plays • Length 2:32Download video MP4
Download video MP3
Similar videos
-
3:23
phase i study of cd22 car-t therapy in patients with lbcl who have relapsed after cd19 car-t therapy
-
3:18
evaluating dual-targeting cd19/22 car-t cells in patients with r/r all
-
1:21
anti-cd22 car t-cell therapy for all: trial update, utility for salvage and cd19 status
-
1:52
opportunities and challenges for dual-targeting car-t therapy in all
-
3:34
humanized versus murinized cd19/cd22 car-t cell therapy for r/r b-cell lymphoma
-
2:01
advances in cd22/cd19 car-t sequential therapy
-
2:27
the potential of car t-cell therapy in combination with antibodies for the treatment of all
-
6:57
mrd negative complete remissions following anti-cd22 car in relapsed/refractory all
-
3:35
phase i/ii trial of p-bcma-101 car-t cell therapy in r/r myeloma
-
1:39
phase i/ii trial of adct-602 in b-all
-
3:38
mechanisms of resistance to car-t in all: t-cell fitness, antigen loss and immunological rejection
-
6:27
day 1 mtt assay video protocol_ cell block
-
2:46
initial guide production and clinical video(eng)
-
2:36
introduction to the request study
-
5:13
masterclass workshop haematology hands-on course point pf care coagulation